Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.